Tuesday, May 24, 2005

Genentech says eye drug improves vision
Preliminary trial results also show that Lucentis met the primary goal of stabilizing vision in patients with wet age-related macular degeneration, which afflicts an estimated 1.2 million Americans, mostly over the age of 50.